Adelo Eyerusalem Shello, Ergena Asrat Elias, Emiru Yohannes Kelifa, Ayele Sileshi, Muche Haymanot Alem
Department of Midwifery, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Pharmaceutical Chemistry, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Int J Womens Health. 2023 Apr 11;15:559-569. doi: 10.2147/IJWH.S388656. eCollection 2023.
Pregnant women are expected to take one or more dietary supplements (DS) like iron, folic acid, zinc, calcium, magnesium, prenatal vitamins, etc. for maternal and child health during pregnancy. Despite its growing use in Ethiopia, data concerning currently marketed maternal DS products have not been intensively investigated so far. Taking into consideration the existing problem, this study was set out to assess the prevalence and commonly used DS during pregnancy in a referral hospital in Ethiopia.
A facility based cross-sectional study was employed to conduct this study from November 2020 to January 2021. The sample size was obtained by using the single population proportion formula and participants were selected and approached by using a systematic random sampling technique. Data were collected through a semi-structured interviewer-administered questionnaire. Descriptive statistics including frequencies and percentages were used to describe continuous and categorical variables and multivariate logistic regression was used to observe the association of the independent variables to the dependent variable.
The overall prevalence of DS use was 84.2% and the most used product was Fefol (iron and folate supplement) (62.4%). A majority (87.8%) of DS products were obtained by prescription. In multivariate regression analysis, DS use during pregnancy was significant among nulliparous women and women who went to college and above [adjusted odds ratio (AOR): 8.142, 95% confidence interval (CI) (1.298-51.070)] and [AOR: 9.259, 95% CI (1.998-42.906)], respectively.
Even though the prevalence of DS practice showed improvement among the study participants, the duration of the DS intake is less than that recommended by the WHO. Pregnant women who did not have birth before and who went to college or above showed significant association with the use of DS.
孕妇在孕期需要服用一种或多种膳食补充剂(DS),如铁、叶酸、锌、钙、镁、产前维生素等,以保障母婴健康。尽管在埃塞俄比亚其使用越来越普遍,但目前市场上销售的孕产妇DS产品的数据迄今尚未得到深入调查。考虑到现有问题,本研究旨在评估埃塞俄比亚一家转诊医院孕期DS的使用 prevalence 及常用DS。
采用基于机构的横断面研究,于2020年11月至2021年1月开展此项研究。样本量通过单总体比例公式获得,参与者采用系统随机抽样技术进行选择和接触。数据通过半结构化访谈式问卷收集。包括频率和百分比在内的描述性统计用于描述连续和分类变量,多变量逻辑回归用于观察自变量与因变量的关联。
DS使用的总体 prevalence 为84.2%,最常用的产品是Fefol(铁和叶酸补充剂)(62.4%)。大多数(87.8%)的DS产品是通过处方获得的。在多变量回归分析中,孕期DS的使用在未生育妇女和上过大学及以上的妇女中具有显著性[调整后的优势比(AOR):8.142,95%置信区间(CI)(1.298 - 51.070)]和[AOR:9.259,95%CI(1.998 - 42.906)],分别。
尽管研究参与者中DS使用的 prevalence 有所改善,但DS摄入的持续时间低于世界卫生组织推荐的时间。未生育且上过大学或以上的孕妇与DS的使用显示出显著关联。